BlueCrest Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

BlueCrest Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-22,922	Closed	-$656K	–	1478
2018 Q4	$656K	Sell	22,922 -14,405	-39%	-$409K	0.03%	291
2018 Q3	$1.04M	Buy	37,327 +2,076	+6%	+$58.4K	0.03%	431
2018 Q2	$984K	Sell	35,251 -25,274	-42%	-$678K	0.03%	533
2018 Q1	$1.5M	Buy	60,525 +20,275	+50%	+$493K	0.05%	371
2017 Q4	$975K	Buy	+40,250	New	+$1.06M	0.03%	390

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

BlueCrest Capital Management's NXTM Position: Q1 2019 in Review

BlueCrest Capital Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 22,922 shares — an estimated $656K sold.

BlueCrest Capital Management first reported a position in NXTM in Q4 2017 and held it in 5 quarters. The position peaked at $1.5M in Q1 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

BlueCrest Capital Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
BlueCrest Capital Management sold 22,922 NxStage Medical Inc. shares in Q1 2019, an estimated $656K.
BlueCrest Capital Management first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 5 quarters.
BlueCrest Capital Management's NxStage Medical Inc. position peaked at $1.5M in Q1 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on BlueCrest Capital Management's 13F filing for Q1 2019, filed 15 May 2019.